Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Krsnaa DiagnosticsNSE:KRSNAA -0.50%64 PB Ratio is 1.79 as of Jul. 28, 2026, which is 29% below its 10-year median of 2.53. GuruFocus rates NSE:KRSNAA with a GF Score™ of 64/100 and a GF Value™ of ₹920.99 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, Krsnaa Diagnostics ranks better than 57.73% on this metric.
Krsnaa Diagnostics Ltd stock PB Ratio (=1.79) is close to 5-year low of 1.76.
The historical rank and industry rank for Krsnaa Diagnostics's PB Ratio or its related term are showing as below:
NSE:KRSNAA'
s PB Ratio Range Over the Past 10 Years
Min: 1.76 Med: 2.53 Max: 3.98
Current: 1.78
During the past 8 years, Krsnaa Diagnostics's highest PB Ratio was 3.98. The lowest was 1.76. And the median was 2.53.
NSE:KRSNAA's PB Ratio is ranked better than 57.73% of 194
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.045
vs NSE:KRSNAA: 1.78
During the past 12 months, Krsnaa Diagnostics's average Book Value Per Share Growth Rate was 10.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 8.70% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Krsnaa Diagnostics was 8.70% per year. The lowest was 7.80% per year. And the median was 8.25% per year.
Back to Basics: PB Ratio
Krsnaa Diagnostics (NSE:KRSNAA) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Krsnaa Diagnostics PB Ratio Related Terms
Krsnaa Diagnostics PB Ratio Historical Data
* Premium members only.
The historical data trend for Krsnaa Diagnostics's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Krsnaa Diagnostics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krsnaa Diagnostics PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Krsnaa Diagnostics's PB Ratio distribution charts can be found below:
* The bar in red indicates where Krsnaa Diagnostics's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Krsnaa Diagnostics (NSE:KRSNAA) has a PB Ratio of 1.79 as of Jul. 28, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Krsnaa Diagnostics and its competitors. This is 29% below median its historical median of 2.53. Over the past decade, Krsnaa Diagnostics' PB Ratio has ranged from 1.76 to 3.98. According to the industry distribution chart, Krsnaa Diagnostics ranks #82 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 42.3%.
Is Krsnaa Diagnostics' PB Ratio too high?
Krsnaa Diagnostics' current PB Ratio of 1.79 is 29% below median its 10-year median of 2.53. Over the past 10 years, this metric has ranged from a low of 1.76 to a high of 3.98. The Medical Diagnostics & Research industry median PB Ratio is 2.05. Krsnaa Diagnostics' value of 1.79 is 12.5% below this industry median. Based on the distribution chart, Krsnaa Diagnostics ranks #82 out of 194 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Krsnaa Diagnostics has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krsnaa Diagnostics' PB Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Krsnaa Diagnostics ranks #82 out of 194 companies for PB Ratio. This puts Krsnaa Diagnostics in the upper half of its industry. The industry median PB Ratio is 2.05. Krsnaa Diagnostics' value of 1.79 is 12.5% below this benchmark. Historically, Krsnaa Diagnostics' own PB Ratio has ranged from 1.76 to 3.98 over the past decade. While the company's 10-year median is 2.53 vs. the industry median of 2.05, Krsnaa Diagnostics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 2.05, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krsnaa Diagnostics's current PB Ratio of 1.79 is 12.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Krsnaa Diagnostics and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krsnaa Diagnostics's current PB Ratio is 1.79, which is 29% below median its own 10-year median of 2.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krsnaa Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Krsnaa Diagnostics (NSE:KRSNAA) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹920.99, compared to a current price of ₹542.10 — trading 41.1% below its estimated fair value. The current PB Ratio is 1.79, which is 29% below median its 10-year median of 2.53 and 12.5% below the Medical Diagnostics & Research industry median of 2.05. Krsnaa Diagnostics' overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Krsnaa Diagnostics (NSE:KRSNAA), the current PB Ratio is 1.79 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krsnaa Diagnostics (NSE:KRSNAA) Overvalued in 2026?
Based on GuruFocus' analysis, Krsnaa Diagnostics stock appears to be undervalued.
The current stock price of ₹542.10 is trading 41.1% below its estimated GF Value™ of ₹920.99.
GuruFocus considers Krsnaa Diagnostics to be Significantly Undervalued.
Key valuation signals for NSE:KRSNAA:
PB Ratio: 1.79 (29% below median its 10-year median of 2.53)
GF Value™: ₹920.99 vs. price of ₹542.10 (41.1% below fair value)
Industry Position: 12.5% below the Medical Diagnostics & Research median (#82 of 194)
No single metric tells the full story. See the NSE:KRSNAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, tele-reporting services, and all types of Blood and Urine investigations.
64GF Score
Get the complete analysis for NSE:KRSNAA
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KRSNAA has been successfully added to your 
